This a million dollar question, and one that different clinics are taking different approaches
The pharmacy couldnt provide complete documentation about the formulation
However, everyone's biology is unique
The evidence is not that clean yet
Ozempic is injected once a week using a pre-filled pen device
There are several types of GLP medications that engage different types of glucagon receptors, giving them different effects in different people: Single receptor agonists (GLP-1 only): Ozempic, Wegovy, Saxenda Dual receptor agonists (GLP-1 + GIP): Mounjaro, Zepbound Triple receptor agonists (GLP-1 + GIP + glucagon): in development early studies show even greater metabolic effects These medications are changing how we are able to ameliorate obesity, food addiction, insulin resistance, and cardiometabolic risks